XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Revenue (Tables)

6 Months Ended

Jun. 30, 2024

Revenue

Schedule of Net product revenue in United States, and Company's net revenue

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

June 30,

​

June 30,

(in thousands)

2024

​

2023

​

2024

2023

Products

​

​

​

​

​

​

​

​

​

​

​

​

UDENYCA

​

$

50,917

​

$

31,729

​

$

93,584

​

$

57,908

CIMERLI

​

​

—

​

​

26,728

​

​

28,194

​

​

32,902

YUSIMRY

​

​

3,766

​

​

—

​

​

7,660

​

​

—

LOQTORZI

​

​

3,789

​

​

—

​

​

5,777

​

​

—

Total net product revenue

​

​

58,472

​

​

58,457

​

​

135,215

​

​

90,810

Other revenue

​

6,507

​

259

​

6,827

​

342

Total net revenue

​

$

64,979

​

$

58,716

​

$

142,042

​

$

91,152

Schedule of Gross Revenues by Significant Customer as a Percentage of Total Gross Revenues

Gross product revenues by significant customer as a percentage of total gross product revenues were as follows:

​	​	​	​	​	​	​	​	​	​	​	​	​
​		Three Months Ended					​	Six Months Ended
​	​	June 30,					​	June 30,				​
​	​	2024		​	2023	​	​	2024		​	2023
McKesson Corporation		38	%	​	34	%	​	40	%	​	34	%
Cencora (previously known as AmeriSource-Bergen Corporation)		41	%	​	50	%	​	41	%	​	47	%
Cardinal Health, Inc.		19	%	​	14	%	​	17	%	​	17	%

Schedule of Activities and Ending Reserve Balances for Each Significant Category of Discounts and Allowances

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Six Months Ended June 30, 2024

​

Chargebacks

​

​

Other Fees,

​

​

​

​

and Discounts

​

​

​

​

Co-pay

​

​

​

​

​

for Prompt

​

​

​

​

Assistance

​

​

​

(in thousands)

​

Payment

​

Rebates

​

and Returns

​

Total

Balances at December 31, 2023

​

$

73,953

​

$

121,137

​

$

49,795

​

$

244,885

Provision related to sales made in:

​

​

​

​

​

​

​

​

​

​

​

​

Current period

​

​

486,139

​

​

109,615

​

​

80,252

​

​

676,006

Prior period - increase (decrease)

​

​

(816)

​

​

6,145

​

​

(1,263)

​

​

4,066

Payments and customer credits issued

​

(485,633)

​

​

(105,986)

​

​

(82,240)

​

​

(673,859)

Balances at June 30, 2024

​

$

73,643

​

$

130,911

​

$

46,544

​

$

251,098

​

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

​

​

Six Months Ended June 30, 2023

​

Chargebacks

​

​

Other Fees,

​

​

​

​

and Discounts

​

​

​

​

Co-pay

​

​

​

​

​

for Prompt

​

​

​

​

Assistance

​

​

​

(in thousands)

​

Payment

​

Rebates

​

and Returns

​

Total

Balances at December 31, 2022

​

$

42,677

​

$

38,713

​

$

19,113

​

$

100,503

Provision related to sales made in:

​

​

​

​

​

​

​

​

​

​

​

​

Current period

​

226,074

​

​

45,009

​

​

37,936

​

​

309,019

Prior period - increase (decrease)

​

​

(1,380)

​

​

1,059

​

​

3,830

​

​

3,509

Payments and customer credits issued

​

(217,014)

​

(27,332)

​

(34,118)

​

(278,464)

Balances at June 30, 2023

​

$

50,357

​

$

57,449

​

$

26,761

​

$

134,567

​

X

- Definition

Schedule of product sales discounts and allowances.

+ References

No definition available.

+ Details

Name:	chrs_ScheduleOfProductSalesDiscountsAndAllowancesTableTextBlock
Namespace Prefix:	chrs_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-20

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 16
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-16

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-21

+ Details

Name:	us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration